Brenda Herschbach Jarrell > Choate, Hall & Stewart > Boston, United States > Lawyer Profile
Choate, Hall & Stewart Offices
TWO INTERNATIONAL PLACE
BOSTON, MA 02110
MASSACHUSETTS
United States
- Firm Profile
- Go to...
Brenda Herschbach Jarrell
Position
Dr. Brenda Herschbach Jarrell, chair of Choate’s Life Sciences Group, is described by clients as an IP lawyer with keen business savvy. Her extensive technical credentials make her well-versed in a wide variety of technologies in the biotech, pharmaceutical, and specialty chemical industries. She represents companies and institutions at all stages of the life sciences business lifecycle, as well as those who invest in them, guiding IP protection and competitive positioning strategies, negotiating strategic transactions, and providing creative solutions to IP and technology-related challenges. Throughout her career, Brenda has advised multiple clients from Series A through their eventual IPOs.
As one of the foremost respected IP strategists in the country, Brenda is routinely awarded the recognition of “Attorney of the Year” by several respected rankings providers across a variety of categories.
Some of her clients include Adimab, Aleta Biotherapeutics, Angion Biomedica Corp., Apellis Pharmaceuticals, Atlas Venture, Base Genomic, Biogen, BioNTech, Casma Therapeutics, Celsius Therapeutics, Eirion Therapeutics, FogPharma, FORMA Therapeutics, Gilead, Ginkgo BioWorks, Kernal Biologics, LogicBio Therapeutics, Mereo BioPharma, Olema Pharmaceuticals, Progenics Pharmaceuticals, Regeneron Pharmaceuticals, ReNetX Bio, Scipher Medicine Corporation, STIMIT Corporation, Syros Pharmaceuticals, Third Rock Ventures, WAVE Life Sciences, and Venrock.
Brenda is a member of Choate’s Executive Committee.
Education
- Harvard Law School
- JD, 1998, cum laude
- University of California at San Francisco
- PhD, 1993
- Biochemistry and Molecular Biology
- Harvard University
- MA, 1988, magna cum laude
- Chemistry
- Harvard University
- AB, 1988, magna cum laude
- Chemistry
Lawyer Rankings
United States > Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
(Leading partners)From the firm’s Boston base, pharma research specialist Kristen Buteau and Brian Reese co-lead Choate, Hall & Stewart‘s patent prosecution group which is noted as making ‘everything so easy for the client’. The team has a focus on life sciences-related work in particular; expert in the sector Brenda Herschbach Jarrell is a standout member of the cohort, who is highlighted as being ‘particularly creative with her IP solutions for many prosecution, diligence and other matters’. The ‘truly exceptional’ Charles Lyon is equipped to assist investors and life sciences companies in their IP matters, while Stephanie Schonewald has particular expertise handling potentially contentious cases for biotech and pharma companies. Attorney John Rearick departed to Dechert LLP in July 2023.
Lawyer Rankings
- Leading partners United States > Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- Patents: prosecution (including re-examination and post-grant proceedings) United States > Intellectual property
Top Tier Firm Rankings
- Boston Elite > Commercial litigation
- Boston Elite > Corporate & M&A
- Boston Elite > Commercial litigation
Firm Rankings
- Insurance > Advice to insurers
- Boston Elite > Commercial litigation
- Industry focus > Education
- M&A/corporate and commercial > M&A: middle-market (sub-$500m)
- M&A/corporate and commercial > Private equity buyouts: middle-market (Up to $500m)
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- M&A/corporate and commercial > Venture capital and emerging companies
- Real estate > Real estate
- Finance > Restructuring (including bankruptcy): corporate
- Tax > US taxes: non-contentious